The degree of hemolysis is an essential indicator of the quality and integrity of blood products. With the HemoCue® Plasma/Low Hb System, you can easily and accurately estimate hemolysis directly at the point of care. Replace subjective visual judgment and have confidence in your answers.
Key benefits
In the laboratory, hemolysis is an important preanalytical factor that affects the accuracy and clinical utility of many test results. By assessing the degree of hemolysis before analysis, the sample can be accepted or rejected. The HemoCue® Plasma/Low Hb System makes it possible to easily and accurately estimate hemolysis without having to send the sample to a lab.
02 Portability enables testing anywhere
03 Precise factory calibration against the ICSH reference method
04 Brief training with virtually no maintenance
05 Proprietary microcuvette technology with excellent lot-to-lot reproducibility
06 Blood-based liquid controls available
System specifications
Principle
Modified azidemethemoglobin reaction; dual wavelengths (570 nm and 880 nm) for compensation of turbidity
Calibration
Factory calibrated against the ICSH reference method; needs no further calibration
Power
AC adapter or 5 AA batteries
Quality control
Two levels of liquid controls
Operating temperature
15-30°C (59-86°F)
Storage temperature
Photometer: 0-50°C (32-122°F)
Microcuvettes: unopened 15-30°C (59-86°F); three-month open vial stability
Sample material
Plasma, serum, aqueous solutions or supernatant from erythrocyte suspensions
Measurement range
0.3-30.0 g/L
(0.03-3.0 g/dL, 30.0-3000 mg/dL, 0.02-1.86 mmol/L)